Profil
Mark Schoenfisch is the founder.
Dr. Schoenfisch was the founder of NVN Liquidation, Inc. and held the title of Secretary from 2006 to 2016.
Dr. Schoenfisch is the founder of Vast Therapeutics, Inc. and holds the title of Director & Chief Scientific Officer since 2017.
Dr. Schoenfisch is also the founder of Diabetic Health, Inc. Dr. Schoenfisch is currently the Chief Scientific Officer at KNOW Bio LLC.
Postes actifs de Mark Schoenfisch
| Sociétés | Poste | Début |
|---|---|---|
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Directeur Technique/Scientifique/R&D | - |
Diabetic Health, Inc.
Diabetic Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops novel sensing technologies for use in hospital | Fondateur | - |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Fondateur | 05/04/2017 |
Anciens postes connus de Mark Schoenfisch
| Sociétés | Poste | Fin |
|---|---|---|
| NVN LIQUIDATION, INC. | Fondateur | 08/02/2016 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NVN Liquidation, Inc.
NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Health Technology |
Diabetic Health, Inc.
Diabetic Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops novel sensing technologies for use in hospital | Electronic Technology |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Health Technology |
















